Stock Offerings
Secondary · ATM · Shelf · PIPE Guide↗
858 results
858
Total Filings
$6907.5B
Total Raised
65
424B4 Offerings
248
ATM Programs
106
PIPEs
| Date ▼ | Ticker | Sector | Industry | Mkt Cap | Type | Offer Price | Price | vs Offer | Shares | Proceeds | Underwriters | Summary |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 | SMR | Utilities | Renewable Utilities | $2.9B | ATM | — | $9.61 | — | — | — | UBS, B. Riley | NuScale Power Corporation is selling up to $1 billion of Class A Common Stock through four sales agents at market prices, with proceeds for general corporate purposes. |
| Feb 26 | KYMR | Healthcare | Biotechnology | $9.4B | ATM | — | $114.76 | — | — | — | Cowen | Kymr will sell up to $500 million in common stock at-the-market through TD Cowen, with proceeds for general corporate purposes and a 3% sales commission. |
| Feb 26 | VIR | Healthcare | Biotechnology | $1.7B | Public Offering | — | $10.02 | — | 17.6M | — | Evercore, Barclays | Virologic (VIR) is offering 17,647,059 common shares at $8.50 per share for $150 million gross proceeds, with net proceeds of approximately $141.75 million before expenses. |
| Feb 26 | LPCN | Healthcare | Biotechnology | $14M | ATM | — | $2.47 | — | 1.6M | — | — | Lipocine Inc. (LPCN) is increasing its at-the-market offering to $50 million total common stock through A.G.P./Alliance Global Partners, with $39.4 million available for new sales after prior $10.6 million sold. |
| Feb 25 | RVMDW | — | — | — | ATM |
$102.74
floor
|
— | — | — | — | Cowen | Revmd may sell up to $1 billion in common stock at-the-market through TD Cowen, with last price $102.74/share; proceeds for general corporate purposes. |
| Feb 25 | LYTS | Technology | Hardware, Equipment & Parts | $800M | Public Offering |
$21.96
floor
|
$25.67 | +16.9% | — | — | Oppenheimer | # LYTS Offering Summary Lyts is raising $90 million through a common stock offering at an undisclosed price per share (last trade $21.96), with proceeds for unspecified corporate purposes. |
| Feb 25 | CISS | Industrials | Marine Shipping | $331,687 | ATM | — | $1.88 | — | — | — | — | C3IS Inc. is raising up to $98 million through at-the-market sales of common stock via Aegis Capital Corp., with proceeds for general corporate purposes. |
| Feb 25 | MCB | Financial Services | Banks - Regional | $1.0B | Public Offering |
$90.78
floor
|
$100.21 | +10.4% | — | — | UBS | Metropolitan Bank Holding Corp. is offering shares of common stock to raise $175 million for organic growth initiatives, bank investments, working capital, and general corporate purposes. |
| Feb 25 | RXRX | Healthcare | Biotechnology | $1.8B | ATM | — | $3.96 | — | — | — | Cowen | Recursion Pharmaceuticals is offering up to $300 million of Class A Common Stock at-the-market through TD Securities, with proceeds for general corporate purposes; stock trading at $3.53/share on February 24, 2026. |
| Feb 25 | HUT | Financial Services | Financial - Capital Markets | $11.7B | ATM | — | $103.78 | — | — | — | Cantor Fitzgerald, Needham, Stifel | HUT is issuing up to $1 billion in common stock through an at-the-market offering via multiple sales agents on Nasdaq and other venues, with proceeds for general corporate purposes. |
| Feb 25 | EP | Energy | Oil & Gas Exploration & Production | $103M | Public Offering |
$2.99
floor
|
$2.60 | -13.0% | 3.3M | $10M | — | Empire Petroleum Corporation is raising up to $10.0 million by selling 3,344,482 subscription rights at $2.99 per share to existing shareholders; proceeds will support general corporate purposes. |
| Feb 25 | IPWR | Industrials | Electrical Equipment & Parts | $42M | Public Offering | — | $4.95 | — | 3.5M | — | — | Ideal Power Inc. is selling 3,505,855 common shares and pre-funded warrants for 952,881 shares at undisclosed pricing; proceeds will be used for general corporate purposes. |
| Feb 25 | BRN | Energy | Oil & Gas Exploration & Production | $11M | ATM | — | $0.98 | — | — | — | — | Barnwell Industries selling up to $3.2 million of common stock at-the-market through Roth Capital Partners; proceeds for general corporate purposes, with 2.5% sales agent commission. |
| Feb 25 | LRMR | Healthcare | Biotechnology | $282M | Public Offering |
$3.69
floor
|
$3.29 | -10.8% | — | — | J.P. Morgan | Larimar Therapeutics raising $75 million through common stock and pre-funded warrant offering; proceeds for general corporate purposes and working capital. |
| Feb 25 | VGZ | Basic Materials | Gold | $269M | Secondary | — | $1.84 | — | — | — | — | Vista Gold Corp is offering $30 million of common shares at an undisclosed price per share through CIBC World Markets Inc., with proceeds for general corporate purposes. |
| Feb 25 | ZURA | Healthcare | Biotechnology | $349M | Public Offering | — | $5.36 | — | — | — | Piper Sandler | Zurify Inc. (ZURA) is offering 18.2 million Class A ordinary shares and 1.8 million pre-funded warrants at $6.25 per share/$6.249 per warrant, raising approximately $125 million gross proceeds. |
| Feb 24 | OGS | Utilities | Regulated Gas | $4.7B | Public Offering | — | $75.65 | — | — | — | BofA, J.P. Morgan, RBC Capital, Truist, Bank of America, JPMorgan | ONE Gas, Inc. selling up to $225 million in common stock through equity distribution agreement with seven managers at market prices on NYSE; proceeds for general corporate purposes. |
| Feb 24 | VIR | Healthcare | Biotechnology | $1.7B | Public Offering | — | $10.02 | — | — | — | Evercore, Barclays | Vir Biotechnology is selling $200 million of common stock at an offering price to be determined, with proceeds used for general corporate purposes. |
| Feb 24 | PVLA | Healthcare | Biotechnology | $1.7B | Public Offering | — | $140.31 | — | — | — | Cowen, Stifel, Oppenheimer | Privium Capital Inc. (PVLA) is raising $150 million through a public offering of common stock and pre-funded warrants, with proceeds to be used for general corporate purposes. |
| Feb 24 | ABTS | Financial Services | Financial - Capital Markets | $3M | Public Offering |
$3.73
floor
|
$1.22 | -67.3% | — | — | — | ABITS Group Inc. is offering up to 792,452 ordinary shares and/or Pre-Funded Warrants at $2.65 per share/$2.64999 per warrant to institutional investors, with proceeds for general corporate purposes. |
Data sourced from SEC EDGAR 424B4, 424B5, and 8-K filings. IPOs hidden by default.
Learn more →